Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Prior to Transplant in Patients With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib for Chuvash Polycythemia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE1
Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
- Status
- COMPLETED
- Phase
- PHASE3
A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2